2018 International Congress

October 5-9, 2018. Hong Kong. Abstracts are presented on the 6th, 7th, and 8th.

View by Title View Sessions

View by Date

Saturday, October 6, 2018

1:45pm-3:15pm: Changes in chest wall intermuscular coherence and speech breathing kinematics during speech and non-speech tasks following LSVT LOUD® in children with dysarthria secondary to cerebral palsy

M. Ho, A. Reed, B. Mager, H. Gynane, R. Bakhtiari, C. Fox, C. Boliek (Edmonton, AB, Canada)

Pediatric Movement Disorders · Hall 3FG

1:45pm-3:15pm: Characteristics of dopaminergic treatments in advanced Parkinson’s before levodopa-carbidopa intestinal gel infusion: Data from 107 tested patients

J. Szasz, V. Constantin, K. Orban-Kis, L. Bancu, D. Georgescu, J. Szederjesi, I. Mihaly, S. Szatmari (Tirgu Mures, Romania)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment · Hall 3FG

1:45pm-3:15pm: Characterization of color vision impairment in Lewy Body Diseases

T. Tousi, F. Flanigan, K. Khosravi (Cleveland, OH, USA)

Cognitive Disorders · Hall 3FG

1:45pm-3:15pm: Chinese patients with Wilson disease and the treatments: exampled with Unithiol (DMPS) intravenous infusion

X.P. Wang (Shanghai, China)

Rare Genetic and Metabolic Diseases · Hall 3FG

1:45pm-3:15pm: Chitotriosidase is a biomarker for Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP)

S. Hayer, J. Böhringer, L. Schöls (Tübingen, Germany)

Rare Genetic and Metabolic Diseases · Hall 3FG

1:45pm-3:15pm: Chlorogenic acid exerts anti-neuroinflammatory effect by suppressing NF-κB pathway in Parkinsonian mice model

S. Singh, S. Rai, H. Birla, W. Zahra, S. Singh (Varanasi, India)

Neuropharmacology · Hall 3FG

1:45pm-3:15pm: Choice for deep brain stimulation in Parkinson’s disease: Italian survey study

R. Ferrucci, C. Di Nuzzo, F. Ruggiero, F. Mancini, A. Priori (Milan, Italy)

Surgical Therapy: Parkinson's Disease · Hall 3FG

1:45pm-3:15pm: Classifying Parkinsonian Gait and Turning in Daily Life with Wearable Technology

F. Horak, J. McNames, M. El Gohary, J. Nutt, C. Curtze (Portland, OR, USA)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment · Hall 3FG

1:45pm-3:15pm: Clinical and genetic heterogeneity in portuguese patients with Hereditary Spastic Paraplegia

I. Cunha, A. Brás, J. Ribeiro, C. Januário (Coimbra, Portugal)

Genetics (Non-PD) · Hall 3FG

1:45pm-3:15pm: Clinical and genetics characterization of patients with Myoclonus Dystonia Syndrome

B. Perez-Dueñas, M. Vanegas, L. Marti, A. Darling, D. Ortigoza-Escobar, S. Candela, H. Baide, J. Campistol, S. Aguilera, M. Marti, A. Macaya (Barcelona, Spain)

Myoclonus · Hall 3FG